Involvement of erythropoietin in retinal ischemic preconditioning

Anesthesiology

Volumn 110, Issue 4, 2009, Pages 774-780

  Dreixler, John C ^a   Hagevik, Sarah ^b   Hemmert, Jonathan W ^b   Shaikh, Afzhal R ^a   Rosenbaum, Daniel M ^c   Roth, Steven ^a,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENATURATION; ELECTRORETINOGRAPHY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RETINA GANGLION CELL; RETINA ISCHEMIA; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; ISCHEMIC PRECONDITIONING; METABOLISM; NERVE CELL; PHYSIOLOGY; REPERFUSION INJURY; RETINA; RETINA BLOOD VESSEL; SOLUBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DNA NUCLEOTIDYLEXOTRANSFERASE; ELECTRORETINOGRAPHY; ERYTHROPOIETIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HSP27 HEAT-SHOCK PROTEINS; IN SITU NICK-END LABELING; ISCHEMIC PRECONDITIONING; NEURONS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; REPERFUSION INJURY; RETINA; RETINAL VESSELS; SOLUBILITY;

EID: 65349188089     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31819c4601     Document Type: Article

References (30)

1. Roth S, Li B, Rosenbaum PS, Gupta H, Goldstein IM, Maxwell KM, Gidday JM: Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci 1998; 39:775-85
2. Li B, Roth S: Retinal ischemic preconditioning in the rat: requirement for adenosine and repetitive induction. Invest Ophthalmol Vis Sci 1999; 40:1200-16
3. Li B, Yang C, Rosenbaum DM, Roth S: Signal transduction mechanisms involved in ischemic preconditioning in the rat retina in vivo. Exp Eye Res 2000; 70:755-65
4. Ettaiche M, Heurteaux C, Blondeau N, Borsotto M, Tinel N, Lazdunski M: ATP-sensitive potassium channels (KATP) in retina: A key role for delayed ischemic tolerance. Brain Res 2001; 890:118-29
5. Dreixler JC, Shaikh AR, Shenoy SK, Shen Y, Roth S: Protein kinase C subtypes and retinal ischemic preconditioning. Exp Eye Res 2008; 87:300-11
6. Li Y, Roth S, Laser M, Ma JX, Crosson CE: Retinal preconditioning and the induction of heat-shock protein 27. Invest Ophthalmol Vis Sci 2003; 44:1299-304
7. Roth S, Dreixler JC, Shaikh AR, Lee KH, Bindokas V: Mitochondrial potassium ATP channels and retinal ischemic preconditioning. Invest Ophthalmol Vis Sci 2006; 47:2114-24
8. Roth S, Shaikh AR, Hennelly MM, Li Q, Bindokas V, Graham CE: Mitogen- activated protein kinases and retinal ischemia. Invest Ophthalmol Vis Sci 2003; 44:5383-95
9. Zhang C, Rosenbaum DM, Shaikh AR, Li Q, Rosenbaum PS, Pelham DJ, Roth S: Ischemic preconditioning attenuates apoptosis following retinal ischemia in rats. Invest Ophthalmol Vis Sci 2002; 43:3059-66
10. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck H-H, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren A-L: Erythropoietin therapy for acute stroke is both safe and beneícial. Mol Med 2002;8: 495-505
11. Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, Rosenbaum PS, Cerami A, Brines M, Rosenbaum DM: Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 2002; 99:10659-64
12. Kilic U, Kilic E, Soliz J, Bassetti CI, Gassmann M, Hermann DM: Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J 2005; 19:249-51
13. Grimm C,Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE: HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002; 8:718-24
14. Rex TS, Allocca M, Domenici L, Surace EM, Maguire AM, Lyubarsky A, Cellerino A, Bennett J, Auricchio A: Systemic but not intraocular EPO gene transfer protects the retina from light-and genetic-induced degeneration. J Am Soc Gene Ther 2004; 10:855-61
15. Weishaupt JH, Rohde G, Polking E, Siren A-L, Ehrenreich H, Bahr M: Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004; 45:1514-22
16. Grimm C, Wenzel A, Stanescu D, Samardzija M, Hotop S, Groszer M, Naash M, Gassmann M, Reme C: Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 2004; 24:5651-8
17. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, Takagi H: Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005; 353:782-92
18. Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O, Kawauchi S, Ema M, Shibahara S, Udono T, Tomita K, Tamai M, Sogawa K, Yamamoto M, Fujii-Kuriyama Y: HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 2003; 22:1134-46
19. Singh M, Savitz SI, Hoque R, Rosenbaum PS, Roth S, Rosenbaum DM: Cell-speciíc caspase expression by different neuronal phenotypes in transient retinal ischemia. J Neurochem 2001; 77:466-75
20. Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, Victorov I, Kapinya K, Dirnagl U, Meisel A: Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 2003; 34:1981-6
21. Fenjves ES, Ochoa MS, Cabrera O, Mendez AJ, Kenyon NS, Inverardi L, Ricordi C: Human, nonhuman primate, and rat pancreatic islets express eryth-ropoietin receptors. Transplantation 2003; 75:1356-60
22. Kirkeby A, van Beek J, Nielsen J, Leist M, Helboe L: Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor. J Neurosci Methods 2007; 164:50-8
23. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E: A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999; 19:643-51
24. Wen TC, Rogido M, Genetta T, Sola A: Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain. Neurosci Lett 2004; 355:165-8
25. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM: Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005; 19:2026-8
26. Mullonkal CJ, Toledo-Pereyra LH,: Akt in ischemia and reperfusion. J Invest Surg 2007; 20:195-203
27. Scorziello A, Santillo M, Adornetto A, Dellaversano C, Sirabella R, Damiano S, Canzoniero LMT, Renzo GFD, Annunziato L: NO-induced neuro-protection in ischemic preconditioning stimulates mitochondrial Mn-SOD activity and expression via Ras/ERK1/2 pathway. J Neurochem 2007; 103: 1472-80
28. Whitlock NA, Agarwal N, Ma J-X, Crosson CE: Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci 2005; 46:1092-8
29. Bruey JM, Ducasse C, Bonniaud P: Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000; 2:645-52
30. Sun Y, Zhou C, Polk P, Nanda A, Zhang JH: Mechanisms of erythropoietin-induced brain protection in neonatal hypoxia-ischemia rat model. J Cereb Blood Flow Metab 2004; 24:259-70